PRA Health Sciences Inc. (PRAH)

99.48
0.16 0.16
NASDAQ : Commercial Services
Prev Close 99.32
Open 99.84
Day Low/High 99.06 / 100.55
52 Wk Low/High 82.12 / 121.98
Volume 389.34K
Avg Volume 587.40K
Exchange NASDAQ
Shares Outstanding 65.66M
Market Cap 6.43B
EPS 2.40
P/E Ratio 40.99
Div & Yield N.A. (N.A)

Latest News

Notable Wednesday Option Activity: PRAH, ELAN, SIEN

Notable Wednesday Option Activity: PRAH, ELAN, SIEN

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in PRA Health Sciences Inc , where a total of 3,296 contracts have traded so far, representing approximately 329,600 underlying shares. That amounts to about 90.9% of PRAH's average daily trading volume over the past month of 362,700 shares.

JPMorgan and Funko: 'Mad Money' Lightning Round

JPMorgan and Funko: 'Mad Money' Lightning Round

Jim Cramer weighs in on JPMorgan, PRA Health, and Funko.

Keep Your Head Up: Cramer's 'Mad Money' Recap (Thursday 12/6/18)

Keep Your Head Up: Cramer's 'Mad Money' Recap (Thursday 12/6/18)

Jim Cramer offers his views on how to hang on in scary markets.

Care Innovations® And PRA Health Sciences Announce Strategic Partnership

Care Innovations® And PRA Health Sciences Announce Strategic Partnership

As part of Care Innovations ® focus on expanding into adjacent markets, the company is proud to announce its exclusive global partnership with PRA Health Sciences (NASDAQ:PRAH).

Private Briefing: KKR's Healthcare Deal Spree

Private Briefing: KKR's Healthcare Deal Spree

The healthcare team led by James Momtazee has been very busy, with deals for PharMerica, American Medical Response and Covenant Surgical Partners, among others.

Short Interest Falls 24.3% For PRAH

The most recent short interest data has been released for the 04/28/2017 settlement date, which shows a 380,230 share decrease in total short interest for PRA Health Sciences Inc , to 1,186,518, a decrease of 24.27% since 04/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Parexel Is Discovering the Drugs of the Future

Parexel Is Discovering the Drugs of the Future

The midcap drug maker is finding growth as an outsourcing destination.

TheStreet Quant Rating: B (Buy)